查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611545

植入式神经刺激设备市场规模、份额和趋势分析报告：2025-2030 年按产品类型、应用、最终用途、地区和细分市场进行的预测

Implantable Neurostimulators Market Size, Share & Trends Analysis Report By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Epilepsy), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

植入式神经刺激设备市场成长与趋势

Grand View Research, Inc.最新报告显示，2030年全球植入式神经刺激设备市场规模预计将达到98.7亿美元，2025年至2030年复合年增长率为10.3%。

神经系统疾病的盛行率不断上升以及与之相关的慢性疼痛和不适发生率的上升正在推动市场的发展。

帕金森氏症、癫痫、自发性震颤、慢性疼痛和忧郁症等神经系统疾病的盛行率不断增加，导致对植入式神经刺激设备的需求增加。据世界卫生组织称，2020年全球约有5,000万人患有癫痫症。植入式神经刺激设备用于控制癫痫发作。因此，癫痫患者数量的增加预计将推动市场成长。

此外，随着人口老化，他们变得更容易患神经病变，这预计将成为该市场的影响因素。根据 CDC 的数据，帕金森氏症 (PD) 主要在 60 岁以上的人群中被诊断出来，据估计，帕金森氏症将影响 1.0% 的 60 岁以上人群，到 80 岁时将影响 4%。

此外，市场参与企业对新技术的采用和新产品的采用可能会在预测期内提振市场。例如，2019 年 9 月，雅培用于慢性疼痛管理的 Proclaim XR Rechargeless SCS 系统获得美国FDA核准。

植入式神经刺激设备市场报告亮点

  • 由于脊髓刺激器在慢性疼痛管理方面的有效性，到 2024 年，脊髓刺激设备将占据市场 39.7% 的销售份额。
  • 疼痛管理细分市场在 2024 年以最大的收益占有率占据市场主导地位，这归因于慢性疼痛疾病在全球的流行。
  • 2024 年，医院和门诊手术中心 (ASC) 部门的收益占有率最大。
  • 北美植入式神经刺激设备市场在全球市场占据主导地位，2024年收益占有率为43.7%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 植入式神经刺激设备市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章植入式神经刺激设备市场：产品类型业务分析

  • 产品类型市场占有率，2024 年和 2030 年
  • 产品类型细分仪表板
  • 2018-2030 年按产品类型分類的市场规模、预测与趋势分析
  • 脊髓刺激设备
  • 深层脑部刺激器
  • 荐骨神经刺激器
  • 迷走神经刺激设备
  • 胃电刺激

第五章植入式神经刺激设备市场：应用业务分析

  • 2024年及2030年应用市场占有率
  • 使用细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按应用）
  • 疼痛管理
  • 癫痫
  • 帕金森氏症
  • 尿失禁和大便失禁
  • 胃轻瘫
  • 其他的

第六章 植入式神经刺激设备市场：最终用途业务分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
  • 医院和门诊手术中心 (ASC)
  • 诊所和物理治疗中心
  • 其他的

第七章 植入式神经刺激设备市场：区域、估计与趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Aleva Neurotherapeutics
    • Synapse Biomedical Inc.
    • Nevro Corp.
    • LivaNova PLC
    • NeuroPace, Inc.
    • Inspire Medical Systems, Inc.
    • Cognito Therapeutics
Product Code: GVR-4-68039-159-7

Implantable Neurostimulators Market Growth & Trends:

The global implantable neurostimulators market size is anticipated to reach USD 9.87 billion by 2030, expanding at a CAGR of 10.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of neurological diseases and higher occurrence of associated chronic pain and discomfort are driving the market.

The rising prevalence of neurological diseases such as Parkinson's disease, epilepsy, essential tremor, chronic pain, and depression will result in increased demand for implantable neurostimulators. According to the WHO, in 2020, around 50.0 million people worldwide are suffering from epilepsy. Implanted neurostimulators are used to control epileptic seizures. Thus, increasing people suffering from epilepsy is expected to boost the market growth.

Moreover, the growing base of the aging population is more susceptible to neurological disorders, which is anticipated to be a high-impact rendering driver for this market. According to the CDC, Parkinson's disease (PD) is mostly diagnosed in individuals above the age of 60 and it is projected that PD affects 1.0% of the people over the age of 60 to 4% by age of 80.

Furthermore, the incorporation of new technologies, and the introduction of new products by market players, is likely to boost the market during the forecast period. For instance, in September 2019, Abbott received U.S. FDA approval for its Proclaim XR recharge-free SCS system for the management of chronic pain.

Implantable Neurostimulators Market Report Highlights:

  • The spinal cord stimulators segment dominated the market with a revenue share of 39.7% in 2024, driven by their effectiveness in managing chronic pain conditions.
  • The pain management segment dominated the market with the largest revenue share in 2024, which can be attributed to the prevalence of chronic pain disorders globally.
  • The hospitals & Ambulatory Surgery Centers (ASC) segment dominated the market with the largest revenue share in 2024, driven by their role as primary providers of advanced medical treatments.
  • North America implantable neurostimulators market dominated the global market with a revenue share of 43.7% in 2024, which can be attributed to the high prevalence of chronic pain conditions and neurological disorders in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Implantable Neurostimulators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Implantable Neurostimulators Market: Product Type Business Analysis

  • 4.1. Product Type Market Share, 2024 & 2030
  • 4.2. Product Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2018 to 2030 (USD Billion)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal Cord Stimulators Market, 2018 - 2030 (USD Billion)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep Brain Stimulators Market, 2018 - 2030 (USD Billion)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral Nerve Stimulators Market, 2018 - 2030 (USD Billion)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus Nerve Stimulators Market, 2018 - 2030 (USD Billion)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric Electrical Stimulation Market, 2018 - 2030 (USD Billion)

Chapter 5. Implantable Neurostimulators Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Pain Management
    • 5.4.1. Pain Management Market, 2018 - 2030 (USD Billion)
  • 5.5. Epilepsy
    • 5.5.1. Epilepsy Market, 2018 - 2030 (USD Billion)
  • 5.6. Parkinson's Disease
    • 5.6.1. Parkinson's Disease Market, 2018 - 2030 (USD Billion)
  • 5.7. Urinary and Fecal Incontinence
    • 5.7.1. Urinary and Fecal Incontinence Market, 2018 - 2030 (USD Billion)
  • 5.8. Gastroparesis
    • 5.8.1. Gastroparesis Market, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Implantable Neurostimulators Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) Market, 2018 - 2030 (USD Billion)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & Physiotherapy Centers Market, 2018 - 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 7. Implantable Neurostimulators Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. MEA
    • 7.8.1. MEA Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Type Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Medtronic
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Type Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Boston Scientific Corporation
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Type Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Aleva Neurotherapeutics
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Type Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Synapse Biomedical Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Type Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Nevro Corp.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Type Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. LivaNova PLC
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Type Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. NeuroPace, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Type Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Inspire Medical Systems, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Type Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Cognito Therapeutics
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Type Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global implantable neurostimulators market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 5 Global implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America implantable neurostimulators market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 9 North America implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 10 North America implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 11 U.S. implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 12 U.S. implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 13 U.S. implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 14 Canada implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 15 Canada implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 16 Canada implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 17 Mexico implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 18 Mexico implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Mexico implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Europe implantable neurostimulators market, by country, 2018 - 2030 (USD Billion)
  • Table 21 Europe implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 22 Europe implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Europe implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 UK implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 25 UK implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 26 UK implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 27 Germany implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 28 Germany implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 29 Germany implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 30 France implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 31 France implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 32 France implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 Italy implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 34 Italy implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 35 Italy implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 36 Spain implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 37 Spain implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 38 Spain implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 39 Norway implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 40 Norway implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 41 Norway implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 42 Denmark implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 43 Denmark implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Denmark implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Sweden implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 46 Sweden implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Sweden implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific implantable neurostimulators market, by country, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 52 Japan implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 53 Japan implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Japan implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 55 China implantable neurostimulators market, by product type, 2018-2030 (USD Billion)
  • Table 56 China implantable neurostimulators market, by application, 2018-2030 (USD Billion)
  • Table 57 China implantable neurostimulators market, by end use, 2018-2030 (USD Billion)
  • Table 58 India implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 59 India implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 60 India implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Australia implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 62 Australia implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 63 Australia implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 64 South Korea implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 65 South Korea implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 66 South Korea implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 67 Thailand implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 68 Thailand implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Thailand implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 70 Latin America implantable neurostimulators market, by country, 2018 - 2030 (USD Billion)
  • Table 71 Latin America implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 72 Latin America implantable neurostimulators market, by application, 2018 - 2030 (USD Billion
  • Table 73 Latin America implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion
  • Table 74 Brazil implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 75 Brazil implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 76 Brazil implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 77 Argentina implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 78 Argentina implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 79 Argentina implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 80 Middle East & Africa implantable neurostimulators market, by country, 2018 - 2030 (USD Billion)
  • Table 81 Middle East & Africa implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 82 Middle East & Africa implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 83 Middle East & Africa implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 84 South Africa implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 85 South Africa implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 86 South Africa implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 90 UAE implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 91 UAE implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 92 UAE implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait implantable neurostimulators market, by product type, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait implantable neurostimulators market, by application, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait implantable neurostimulators market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Implantable neurostimulators market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product type outlook (USD Billion)
  • Fig. 10 Application outlook (USD Billion)
  • Fig. 11 End use outlook (USD Billion)
  • Fig. 12 Competitive landscape
  • Fig. 13 Implantable neurostimulators market dynamics
  • Fig. 14 Implantable neurostimulators market: Porter's five forces analysis
  • Fig. 15 Implantable neurostimulators market: PESTLE analysis
  • Fig. 16 Implantable neurostimulators market: Product Type segment dashboard
  • Fig. 17 Implantable neurostimulators market: Product Type market share analysis, 2024 & 2030
  • Fig. 18 Spinal cord stimulators market, 2018 - 2030 (USD Billion)
  • Fig. 19 Deep brain stimulators market, 2018 - 2030 (USD Billion)
  • Fig. 20 Sacral nerve stimulators market, 2018 - 2030 (USD Billion)
  • Fig. 21 Vagus nerve stimulators market, 2018 - 2030 (USD Billion)
  • Fig. 22 Gastric electrical stimulation market, 2018 - 2030 (USD Billion)
  • Fig. 23 Implantable neurostimulators market: Application segment dashboard
  • Fig. 24 Implantable neurostimulators market: Application market share analysis, 2024 & 2030
  • Fig. 25 Pain management market, 2018 - 2030 (USD Billion)
  • Fig. 26 Epilepsy market, 2018 - 2030 (USD Billion)
  • Fig. 27 Parkinson's disease market, 2018 - 2030 (USD Billion)
  • Fig. 28 Urinary and fecal incontinence market, 2018 - 2030 (USD Billion)
  • Fig. 29 Gastroparesis market, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market, 2018 - 2030 (USD Billion)
  • Fig. 31 Implantable neurostimulators market: End use segment dashboard
  • Fig. 32 Implantable neurostimulators market: End use market share analysis, 2024 & 2030
  • Fig. 33 Hospitals & ambulatory surgery centers (ASC) market, 2018 - 2030 (USD Billion)
  • Fig. 34 Clinics & physiotherapy centers market, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market, 2018 - 2030 (USD Billion)
  • Fig. 36 Implantable neurostimulators market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 50 France country dynamics
  • Fig. 51 France implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 58 Denmark country dynamics
  • Fig. 59 Denmark implantable neurostimulators market, 2018 - 2030 (USD Billion
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 62 Asia Pacific implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 63 Japan country dynamics
  • Fig. 64 Japan implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 65 China country dynamics
  • Fig. 66 China implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 67 India country dynamics
  • Fig. 68 India implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 69 South Korea country dynamics
  • Fig. 70 South Korea implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 71 Australia country dynamics
  • Fig. 72 Australia implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 73 Thailand country dynamics
  • Fig. 74 Thailand implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 75 Latin America implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 76 Brazil country dynamics
  • Fig. 77 Brazil implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 78 Argentina country dynamics
  • Fig. 79 Argentina implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 80 MEA implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 81 South Africa country dynamics
  • Fig. 82 South Africa implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 83 Saudi Arabia country dynamics
  • Fig. 84 Saudi Arabia implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 85 UAE country dynamics
  • Fig. 86 UAE implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 87 Kuwait country dynamics
  • Fig. 88 Kuwait implantable neurostimulators market, 2018 - 2030 (USD Billion)
  • Fig. 89 Company categorization
  • Fig. 90 Company market position analysis
  • Fig. 91 Strategic framework